Proteolytic remodeling of extracellular matrix

Current Opinion in Cell Biology

Volumn 7, Issue 5, 1995, Pages 728-735

  Birkedal Hansen, Henning ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; METALLOPROTEINASE;

ANGIOGENESIS; CATALYSIS; CELL FUNCTION; ENVIRONMENT; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; KERATINOCYTE; MACROMOLECULE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN PROCESSING; REVIEW; TRANSGENE;

ANIMAL; CELL DIVISION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLYCOPROTEINS; HUMAN; METALLOENDOPEPTIDASES; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0029150795     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-0674(95)80116-2     Document Type: Article

References (61)

1. Matrix metalloproteinases: a review
2. Tumor cell interactions with the extracellular matrix during invasion and metastasis
3. A matrix metalloproteinase expressed on the surface of invasive tumor cells
4. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation
5. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas
6. Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured embryo fibroblasts
7. 1 progression mitogenic stimulation, differentiation, and senescence
8. Cloning of cDNA encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family
9. Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22
10. Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family.
11. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development
12. Phenotypic alteration in Fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression
13. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle
14. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones
15. Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds
16. Cell-type-specific regulation of SL-1 and SL-2 genes. Induction of SL-2, but not SL-1, in human keratinocytes in response to cytokines and phorbolesters
17. Collagen-stimulated induction of keratinocyte collagenase is mediated via tyrosine kinase and protein kinase C activities.
18. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
19. Localization of the 92kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization
20. Modulation of matrilysin level in colon carcinoma cell lines affects tumorigenicity in vivo
21. Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin
22. The induction of 72kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent
23. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor
24. Processing of tumour necrosis factor-α precursor by metalloproteinases
25. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
26. Gelatinase A activity directly modulates melanoma cell adhesion and spreading
27. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum
28. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2)
29. Matrix metalloproteinase inhibitor BB-94 (Batimastat) inhibits human colonic tumor growth and spread in a patient-like orthotopic model in nude mice
30. Interstitial collagenase is required for angiogenesis in vitro
31. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression
32. Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itself
33. Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
34. Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor
35. Structure of human neutrophil collagenase reveals large S1′ specificity pocket
36. The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity
37. The NMR structure of the inhibited catalytic domain of human stromelysin-1
38. Matrilysin—inhibitor complexes: common themes among metalloproteinases
39. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A
40. Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts
41. An internal cysteine plays a role in the maintenance of the latency of human fibroblast collagenase
42. The role of the C-terminal domain in collagenase and stromelysin specificity
43. Characterization of Zinc-binding sites in human stromelysin-1: stoichiometry of the catalytic domain and identification of a cysteine ligand in the proenzyme
44. Zinc content of promatrilysin, matrilysin and the stromelysin catalytic domain
45. The second zinc atom in the matrix metalloproteinase catalytic domain is absent in the full-length enzymes: a possible role for the C-terminal domain
46. Functional domains of human TIMP-1 (tissue inhibitor of metalloproteinases)
47. Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13
48. Mutational analysis of residues in and around the active site of human fibroblast-type collagenase
49. Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis and the binding of tissue inhibitor of metalloproteinases-1
50. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family
51. Interleukin-1β and transforming growth factor-α/epidermal growth factor induce expression of Mr 95,000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes
52. Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase 3 (stromelysin 1)
53. Multiple sites of the propeptide region of human stromelysin-1 are required for maintaining a latent form of the enzyme
54. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2
55. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes
56. Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex
57. Mechanism of cell surface activation of 72k-Da type IV collagenase. Isolation of the activated form of the membrane metalloprotease
58. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes
59. The activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin)
60. The activation of human skin fibroblast procollagenase
61. Host-mediated extracellular matrix destruction by metalloproteinases